Infrastructure and Energy Alternatives, Inc. Announces Third Quarter 2018 Results
INDIANAPOLIS, Nov. 08, 2018 (GLOBE NEWSWIRE) — Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) (“IEA” or the “Company”), a leading […]
TSX News -
Waterloo Salted Caramel Porter Arrives Just in Time for the Holidays
KITCHENER, Ontario, Nov. 08, 2018 (GLOBE NEWSWIRE) — Highlights: Rich caramel and a dash of sea salt come together to […]
TSX News -
Conifex Announces Third Quarter Results
VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”, “we” or “us”) (TSX: CFF) today reported […]
TSX News -
Pengrowth Provides Updated 51-101 Reserves Report as at September 30, 2018
Proven and Probable Reserves Increase to 449 Million Barrels of Oil Equivalent CALGARY, Alberta, Nov. 08, 2018 (GLOBE NEWSWIRE) — […]
TSX News -
Knight Therapeutics Reports Third Quarter 2018 Results
MONTREAL, Nov. 08, 2018 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a Canadian specialty pharmaceutical company, today reported financial […]
TSX News -
Torex Announces Q3 2018 Results With Record Gold Production
(All amounts expressed in U.S. Dollars unless otherwise stated) TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Torex Gold Resources Inc. […]
Red Pine Exploration Appoints New Director
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSX-V: RPX) (“Red Pine” or the “Company”) is pleased […]
Integra Intercepts Highest Grades to Date at Florida Mountain Including 20.44 g/t AuEq Over 3.04 m Within a Larger Zone Grading 5.23 g/t AuEq Over 21.33 m
Press Release Highlights: Exploration drilling at Florida Mountain continues to demonstrate high-grade nature of the gold (“Au”)-silver (“Ag”) deposit with […]
Copper Fox Provides Update on Schaft Creek Project
CALGARY, Alberta, Nov. 08, 2018 (GLOBE NEWSWIRE) — Copper Fox Metals Inc. (“Copper Fox” or the “Company”) (TSX-V: CUU – […]
Affimed to Present at the Jefferies 2018 London Healthcare Conference
Heidelberg, Germany, November 8, 2018 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing […]
